Glycolytic activity following anti-CD19 CAR-T cell infusion in non-Hodgkin lymphoma.

Autor: Vallet N; Hematology and Cell Therapy, University Hospital Tours, Tours, France.; Inserm U1069 N2COx, University of Tours, Tours, France., Drieu Larochelle L; Hematology and Cell Therapy, University Hospital Tours, Tours, France., Santiago-Ribeiro MJ; Department Imaging Nuclear Medicine, University Hospital Tours, Tours, France., Villate A; Hematology and Cell Therapy, University Hospital Tours, Tours, France., Eloit M; Hematology and Cell Therapy, University Hospital Tours, Tours, France., Cirée A; Department of Biological Immunology, University Hospital Tours, Tours, France., Zaragoza L; Department of Pharmacy, University Hospital Tours, Tours, France., André V; Department of Pharmacy, University Hospital Tours, Tours, France., Prat-Lepesant M; Etablissement Français du Sang, Tours, France., Hérault O; Inserm U1069 N2COx, University of Tours, Tours, France.; Department of Biological Hematology, University Hospital Tours, Tours, France., Arbion F; Department of Pathology, University Hospital Tours, Tours, France., Blasco H; Department of Biochemistry, University Hospital Tours, Tours, France., Gyan E; Hematology and Cell Therapy, University Hospital Tours, Tours, France.; Inserm U1069 N2COx, University of Tours, Tours, France.

Publikováno v: European journal of clinical investigation [Eur J Clin Invest] 2024 Nov 01, pp. e14342. Date of Electronic Publication: 2024 Nov 01.